TO STUDY OF EFFECT OF AMRITA GUGGULU, RASNASAPTAKA KWATHA AND RUKSHA SWEDA IN THE TREATMENT OF AMAVATA( RHEUMATOID ARTHRITIS).
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2018/10/016096
- Lead Sponsor
- ational Institute Of Ayurveda Jaipur Rajsthan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients willing to sign consent form for the clinical trial.
2.Patients between the age group of 20 to 60 years, irrespective of sex and socio-economic status.
3.Patients having signs and symptoms of â??Amavata rogaâ??(Rheumatoid Arthritis).
4.Patients with chronicity of less than 5 years.
1.Patients having severe joint deformities.
2.Patients suffering from paralysis.
3.Patients having any type of arthopathy such as Neoplasm of spine, Gout, Ankylosing spondylosis, Traumatic arthritis and Pyogenic osteomylitis etc.
4.Patients having associated Cardiac disease, Tuberculosis, Diabetes mellitus, Malignant Hypertension, Renal Function Impairment, Hypothyroidism, RHD etc.
5.Patients with extremely reduced joint space.
6.Pregnant women and lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To aseess the improvement in Subjective parameters i.e. Signs and Symptoms of Amavata(Rheumatoid Arthritis)Timepoint: 30 days for each patient.
- Secondary Outcome Measures
Name Time Method To aseess the improvement in Objective parameters i.e. Laboratory investigation, X-rays ect.Timepoint: 30 days for each patient.